Answers are grounded in this paper and cite their sources.
Acute myeloid leukemia (AML) is heterogenous in its pathogenesis as well as outcomes, which in turn is influenced by patient- and disease-related factors including age, ability to tolerate treatmen...
No takes yet. Share an insight, caveat, or question.
Venugopal et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: